Balaji A, Hsu M, Lin CT, et al. Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes. J Immunother Cancer 2021;9:e001731. doi:10.1136/jitc-2020-001731
The dosage unit mg/kg has been amended to g/kg.
. 2022 Sep 12;10(9):e001731corr1. doi: 10.1136/jitc-2020-001731corr1
Correction: Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
Collection date 2022.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.
PMCID: PMC9472159 PMID: 36096536
This corrects the article "Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes" in volume 9, e001731.